Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists

Journal of Human Hypertension volume 16, pages S34–S37 (2002)Cite this article

Abstract

The endothelium plays a crucial role in the pathogenesis of cardiovascular disease. Endothelial function is attenuated by the presence of different well known cardiovascular risk factors. Evaluation of endothelial vasodilator function serve as an index integrating the overall stress imposed by cardiovascular risk factors and reinforce the suggestion that endothelial dysfunction is an early marker of cardiovascular disease that precedes clinical manifestations. Angiotensin-converting enzyme inhibitors have been shown to reduce the cardiovascular mortality, an effect that could be the consequence of an improvement in the endothelial function. Recent studies have shown that a calcium antagonist might improve the endothelial function, however, there is controversy about this action and also about the potential mechanisms for the effect of a calcium antagonist in the regulation of endothelial function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Moncada S et al. The L-arginine: nitric oxide pathway J Cardiovasc Pharmacol 1991 17: S1–S9

    Article  CAS  Google Scholar 

  2. López-Jaramillo P, Guarner F, Moncada S . Effects of calcium and parathyroid hormone on prostacyclin synthesis by vascular tissue Life Sci 1987 40: 983–986

    Article  Google Scholar 

  3. López-Jaramillo P, González MC, Palmer RMJ, Moncada S . The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone Br J Pharmacol 1990 101: 489–493

    Article  Google Scholar 

  4. Lusher T . The endothelium and cardiovascular disease a complex relation N Engl J Med 1994 330: 1001–1003

    Google Scholar 

  5. Celermajer DS et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 1992 340: 1111–1115

    Article  CAS  Google Scholar 

  6. Dakak N et al. Contribution of nitric oxide to reactive hyperemia. Impact of endothelial dysfunction Hypertension 1998 32: 9–15

    Article  CAS  Google Scholar 

  7. Hijmering ML et al. Non-invasive evaluation of vascular function Eur Heart J 1999 1 (Suppl): M16–M18

    Google Scholar 

  8. Accini JL et al. Colombian study to Assess the use of Noninvasive Determination of Endothelium-mediated Vasodilation (CANDEV). Normal values and factors associated Endothelium 2000 8: 157–166

    Article  Google Scholar 

  9. Schroeder S et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparision with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging Am Heart J 1999 138: 731–739

    Article  CAS  Google Scholar 

  10. Schachinger V, Britten MB, Zeiher AM . Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 2000 101: 1899–1906

    Article  CAS  Google Scholar 

  11. Takase B et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease Am J Cardiol 1998 82: 1535–1539

    Article  CAS  Google Scholar 

  12. Anderson TJ et al. Close relation of endothelial function in the human coronary and peripheral circulation J Am Coll Cardiol 1995 26: 1235–1241

    Article  CAS  Google Scholar 

  13. Suwaidi JA et al. Long-term follow-up ofpatients with mild coronary artery disease and endothelial dysfunction Circulation 2000 101: 948–954

    Article  CAS  Google Scholar 

  14. Neunteufl T et al. Late prognostic value of flow-mediated dilation in the brachial artery ofpatients with chest pain Am J Cardiol 2000 86: 207–210

    Article  CAS  Google Scholar 

  15. Shepherd JH et al. For the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 1995 333: 1301–1307

    Article  CAS  Google Scholar 

  16. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 1994 344: 1383–1389

  17. Luscher T . Endothelial dysfunction: the role and impact of the renin-angiotensin system Heart 2000 84 (Suppl I): i20–i22

    Article  Google Scholar 

  18. Pfeffer MA . ACE inhibition in acute myocardial infarction N Engl J Med 1995 332: 118–120

    Article  CAS  Google Scholar 

  19. The Heart Outcomes Prevention Evaluation Study (HOPE) investigators. Effects of an Angiotensin Converting enzyme inhibitor, Ramipril, on cardiovascular events in high riskpatients N Engl J Med 2000 342: 145–153

  20. SOLVD investigators. Effect of Enalapril on mortality and the development of heart failure in asymptomaticpatients with reduced left ventricular ejection fraction N Engl J Med 1992 327: 685–691

  21. Vanhoutte P . Endothelium-dependent effects of converting-enzyme inhibitors J Cardiovasc Pharmacol 1993 22: S10–S16

    Article  CAS  Google Scholar 

  22. Mancini J et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction inpatients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study Circulation 1996 94: 258–265

    Article  CAS  Google Scholar 

  23. Anderson TJ et al. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation inpatients with coronary disease (BANFF Study) J Am Coll Cardiol 2000 35: 60–66

    Article  CAS  Google Scholar 

  24. Sudhir K et al. Effects of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo: intravascular two-dimensional and doppler ultrasound studies Circulation 1993 87: 931–938

    Article  CAS  Google Scholar 

  25. Griendling KK, Mineri CA, Ollerenshaw JD, Alexander RW . Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ Res 1994 74: 1141–1148

    Article  CAS  Google Scholar 

  26. Frielingsdorf J et al. Normalization of abnormal coronary vasomotion by calcium antagonists inpatients with hypertension Circulation 1996 93: 1380–1387

    Article  CAS  Google Scholar 

  27. Kaufmman P et al. Reversal of abnormal coronary vasomotion by calcium antagonist inpatients with hypercholesterolemia Circulation 1998 97: 1348–1354

    Article  Google Scholar 

  28. Zhang X, Hintze TH . Amlodipin releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent Circulation 1998 97: 576–580

    Article  CAS  Google Scholar 

  29. Kitakaze M et al. Nifedipine-induced coronaryvasodilation in ischemic hearts is attributable to bradykinin-and NO-dependent mechanism in dogs Circulation 2000 101: 311–317

    Article  CAS  Google Scholar 

  30. Ding Y, Vaziri D . Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression J Pharmacol Exp Ther 2000 292: 606–609

    CAS  PubMed  Google Scholar 

  31. Lansman JB, Hallam TJ, Rink TJ . Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers Nature 1987 325: 811–813

    Article  CAS  Google Scholar 

  32. Chen L et al. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects ofvitamin E, lovastatin and amlodipine J Am Coll Cardiol 1997 30: 569–575

    Article  CAS  Google Scholar 

  33. Horning B, Kohler C, Drexler H . Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans Circulation 1997 95: 1115–1118

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto Colombiano de Investigaciones Biomédicas (ICIB), Bucaramanga, Colombia

    P López-Jaramillo & J P Casas

  2. Universidad Industrial de Santander, Colombia

    P López-Jaramillo

Authors
  1. P López-Jaramillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J P Casas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P López-Jaramillo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

López-Jaramillo, P., Casas, J. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists. J Hum Hypertens 16 (Suppl 1), S34–S37 (2002). https://doi.org/10.1038/sj.jhh.1001339

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001339

Keywords

Search

Advanced search

Quick links